Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Graham

Showing results (881-890 of 994) with videos related to

Pageof 100
Sort By:
Surgical Oncology|September 6, 2020
Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approachChing-Wei D Tzeng, Hop S Tran Cao, Christina L Roland, et al.
Surgery|November 22, 2023
Is there a role for liquid biopsy in the surveillance of parathyroid carcinoma?Thomas Szabo Yamashita, Aditya S Shirali, Salyna Meas, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 10, 2021
Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal PolypsJoaquim Mullol, Claus Bachert, Nikhil Amin, et al.
The Journal of Investigative Dermatology|June 29, 2019
IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic DermatitisChris Callewaert, Teruaki Nakatsuji, Rob Knight, et al.
European Journal of Human Genetics : EJHG|May 15, 2014
6q22.1 microdeletion and susceptibility to pediatric epilepsyPrzemyslaw Szafranski, Gretchen K Von Allmen, Brett H Graham, et al.
American Journal of Clinical Dermatology|June 20, 2020
Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic DermatitisLisa A Beck, Diamant Thaçi, Mette Deleuran, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 19, 2021
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthmaTanya M Laidlaw, Claus Bachert, Nikhil Amin, et al.
Nature Communications|March 1, 2024
Warming underpins community turnover in temperate freshwater and terrestrial communitiesImran Khaliq, Christian Rixen, Florian Zellweger, et al.
Science (New York, N.Y.)|July 27, 2013
Response to Comment on "An update of Wallace's zoogeographic regions of the world"Ben G Holt, Jean-Philippe Lessard, Michael K Borregaard, et al.
Advances in Therapy|May 5, 2018
Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe AsthmaWilliam W Busse, Jorge F Maspero, Klaus F Rabe, et al.
Pageof 100

Showing results (881-890 of 994) with videos related to

Sort By:
Pageof 100
Surgical Oncology|September 6, 2020
Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approachChing-Wei D Tzeng, Hop S Tran Cao, Christina L Roland, et al.
Surgery|November 22, 2023
Is there a role for liquid biopsy in the surveillance of parathyroid carcinoma?Thomas Szabo Yamashita, Aditya S Shirali, Salyna Meas, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 10, 2021
Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal PolypsJoaquim Mullol, Claus Bachert, Nikhil Amin, et al.
The Journal of Investigative Dermatology|June 29, 2019
IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic DermatitisChris Callewaert, Teruaki Nakatsuji, Rob Knight, et al.
European Journal of Human Genetics : EJHG|May 15, 2014
6q22.1 microdeletion and susceptibility to pediatric epilepsyPrzemyslaw Szafranski, Gretchen K Von Allmen, Brett H Graham, et al.
American Journal of Clinical Dermatology|June 20, 2020
Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic DermatitisLisa A Beck, Diamant Thaçi, Mette Deleuran, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 19, 2021
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthmaTanya M Laidlaw, Claus Bachert, Nikhil Amin, et al.
Nature Communications|March 1, 2024
Warming underpins community turnover in temperate freshwater and terrestrial communitiesImran Khaliq, Christian Rixen, Florian Zellweger, et al.
Science (New York, N.Y.)|July 27, 2013
Response to Comment on "An update of Wallace's zoogeographic regions of the world"Ben G Holt, Jean-Philippe Lessard, Michael K Borregaard, et al.
Advances in Therapy|May 5, 2018
Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe AsthmaWilliam W Busse, Jorge F Maspero, Klaus F Rabe, et al.
Pageof 100